These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38802072)

  • 41. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections.
    Seaton RA; Sharp E; Bezlyak V; Weir CJ
    Int J Antimicrob Agents; 2011 Sep; 38(3):243-8. PubMed ID: 21741221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A practical program for outpatient parenteral antimicrobial therapy].
    Ravelingien T; Buyle F; Deryckere S; Huis In 't Veld D; Debrauwere M; Verplancke K; Callens S; Commeyne S; Pattyn C; Somers A; Vogelaers D
    J Pharm Belg; 2016 Sep; (3):22-31. PubMed ID: 30281241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers.
    Hassanzai M; Adanç F; Koch BCP; Verkaik NJ; van Oldenrijk J; de Bruin JL; de Winter BCM; van Onzenoort HAW
    Ther Adv Infect Dis; 2023; 10():20499361231214901. PubMed ID: 38127471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Inpatient Antimicrobial Regimens for Readmitted Outpatient Parenteral Antimicrobial Therapy Patients Receiving Daptomycin or Ertapenem for Ease of Administration.
    Britt RS; LaSalvia MT; Padival S; Patel P; McCoy C; Mahoney MV
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz496. PubMed ID: 32128338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years.
    Matthews PC; Conlon CP; Berendt AR; Kayley J; Jefferies L; Atkins BL; Byren I
    J Antimicrob Chemother; 2007 Aug; 60(2):356-62. PubMed ID: 17566002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective evaluation of an intervention bundle on OPAT implementation in a large non-university hospital.
    Missiaen L; Vogelaers D; De Roo PJ; Van Hoecke F; Vanmierlo B; Ravelingien T; Langbeen J
    Acta Clin Belg; 2024 Feb; 79(1):19-25. PubMed ID: 37927057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The history and evolution of outpatient parenteral antibiotic therapy (OPAT).
    Williams DN; Baker CA; Kind AC; Sannes MR
    Int J Antimicrob Agents; 2015 Sep; 46(3):307-12. PubMed ID: 26233483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hidden cost of dalbavancin: OPAT RN time required in coordination for persons who use drugs.
    Douglass AH; Mayer H; Young K; Sikka MK; Strnad L; Makadia J; Sukerman E; Lewis JS; Streifel AC
    Ther Adv Infect Dis; 2023; 10():20499361231189405. PubMed ID: 37581105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.
    Fanucchi LC; Murphy SM; Surratt H; Kapadia SN; Walsh SL; Grubbs JA; Thornton AC; Nuzzo P; Lofwall MR
    Ther Adv Infect Dis; 2022; 9():20499361221108005. PubMed ID: 35847566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy.
    Schrank GM; Wright SB; Branch-Elliman W; LaSalvia MT
    Infect Control Hosp Epidemiol; 2018 Aug; 39(8):947-954. PubMed ID: 29893658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting.
    Kieran J; O'Reilly A; Parker J; Clarke S; Bergin C
    Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1369-74. PubMed ID: 19697069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the utilization and impact of a newly established outpatient parenteral antimicrobial therapy (OPAT) program.
    Yan M; Lam PW; Andany N; Chan AK; Leis JA; Mubareka S; Simor AE; Daneman N
    J Assoc Med Microbiol Infect Dis Can; 2020 Jun; 5(2):70-76. PubMed ID: 36338181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years.
    Li W; Branley J; Sud A
    Infection; 2018 Jun; 46(3):349-355. PubMed ID: 29464675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Opportunities for Oral Antibiotic Therapy in Bone and Joint Infections.
    Bhagat H; Sikka MK; Sukerman ES; Makadia J; Lewis JS; Streifel AC
    Ann Pharmacother; 2023 Feb; 57(2):156-162. PubMed ID: 35656850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
    Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
    Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
    J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.